Article

Exploring plasma cell motility and extracellular matrix protein biomarkers for primary progressive multiple sclerosis: A pilot study

2024-03-18

Abstract excerpt

Primary progressive multiple sclerosis is associated with neurodegeneration and chronic inflammation, and results in the accumulation of gradual disability. This pilot study investigated 92 plasma proteins using proximal extension assay to identify MS subtype-specific biomarkers with a focus on predicting primary progressive MS. We analyzed samples from 66 MS patients (22 relapsing-remitting, 22 secondary progress...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4957f663-05ff-5e0b-8fc6-44b0c97c4849
DOI: 10.1101/2024.03.17.24304435

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring plasma cell motility and extracellular matrix protein biomarkers for primary progressive multiple sclerosis: A pilot studyDOI 10.1101/2024.03.17.24304435Read

Plasma proteome in multiple sclerosis disease progressionSemantic proximity Read

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesSemantic proximity Read

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosisSemantic proximity Read

Proteomics profiling reveals biomarkers for predicting diagnosis, disease activity and long-term disability outcome in multiple sclerosisSemantic proximity Read

Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencingSemantic proximity Read

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read

Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple SclerosisSemantic proximity Read

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisSemantic proximity Read

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current StatusSemantic proximity Read

A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)Semantic proximity Read

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosisSemantic proximity Read